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a b s t r a c t
Proper morphogenesis is essential for both form and function of the mammalian craniofacial skeleton,
which consists of more than twenty small cartilages and bones. Skeletal elements that support the oral
cavity are derived from cranial neural crest cells (NCCs) that develop in the maxillary and mandibular
buds of pharyngeal arch 1 (PA1). Bone Morphogenetic Protein (BMP) signaling has been implicated in
most aspects of craniofacial skeletogenesis, including PA1 development. However, the roles of the BMP
antagonist Noggin in formation of the craniofacial skeleton remain unclear, in part because of its
multiple domains of expression during formative stages. Here we used a tissue-speciﬁc gene ablation
approach to assess roles of Noggin (Nog) in two different tissue domains potentially relevant to
mandibular and maxillary development. We found that the axial midline domain of Nog expression is
critical to promote PA1 development in early stages, necessary for adequate outgrowth of the
mandibular bud. Subsequently, Nog expression in NCCs regulates craniofacial cartilage and bone
formation. Mice lacking Nog in NCCs have an enlarged mandible that results from increased cell
proliferation in and around Meckel's cartilage. These mutants also show complete secondary cleft palate,
most likely due to inhibition of posterior palatal shelf elevation by disrupted morphology of the
developing skull base. Our ﬁndings demonstrate multiple roles of Noggin in different domains for
craniofacial skeletogenesis, and suggest an indirect mechanism for secondary cleft palate in Nogmutants
that may be relevant to human cleft palate as well.
& 2014 Published by Elsevier Inc.
Introduction
Among the most frequently occurring congenital defects in
newborns are craniofacial deformities, such as cleft palate and
micrognathia (Holder-Espinasse et al., 2001; Mossey PA, 2002).
These malformations impact the quality of life due to functional
difﬁculties as well as negative social responses (Pruzinsky, 1992).
The causes of craniofacial deformities are diverse, including
genetic and environmental factors. Yet the underlying genetic
and cellular mechanisms behind the emergence of such deformi-
ties are not well understood.
Mammalian craniofacial skeletal elements consist of more than
20 small bones and cartilages, the size and shape of which are
precisely determined during development (reviewed by Matsui
and Klingensmith (2013)). Most of these skeletal elements are
derived from neural crest cells (NCCs), an ectoderm-derived
multipotent cell population that migrates ventrally from the
closing dorsal neural folds. NCCs take distinct migratory pathways,
with some populating the pharyngeal arches. One such group of
NCCs populates pharyngeal arch 1 (PA1), where it proliferates and
differentiates to give rise to most of the frontal facial skeletal
structures, such as Meckel's cartilage, the mandible and the
maxilla, including the bones of the palate. Although NCCs possess
intrinsic information that promotes differentiation of the facial
skeleton, interactions between NCCs and other tissues such as
ectoderm or endoderm allow molecular signaling between tissues
to ensure proper morphogenesis and development of pharyngeal
arch derivatives (Couly et al., 2002).
Bone morphogenetic protein (BMP) signaling has been impli-
cated as a key regulator of development of NCCs and their
derivatives (Baek et al., 2011; Bonilla-Claudio et al., 2012; Dudas
et al., 2004; Goldstein et al., 2005; Kanzler et al., 2000). Mouse
genetic manipulation studies have revealed a requirement for
precise regulation of BMP signaling in craniofacial development
(Bonilla-Claudio et al., 2012; Li et al., 2013; Wang et al., 2013).
A critical means of regulating BMP signaling is by extracellular BMP
antagonists. Noggin is a major BMP antagonist expressed in multiple
domains during embryonic development. Noggin binds to BMP
ligands in the extracellular space and prevents them from binding
their receptors. Experimental work in mice indicates that Noggin
regulates various types of skeletogenesis, including appendicular bone,
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cartilage and joint formation (Brunet et al., 1998). Genetic studies in
humans have also identiﬁed a role for the NOGGIN gene in regulating
skeletal morphogenesis, with mild ectopic bone formation particularly
in the digits, associated with heterozygous loss-of-function mutations
(reviewed by Potti et al. (2011)).
As demonstrated primarily by analysis of the null phenotypes
of mice lacking the Noggin (Nog) gene, this BMP antagonist also
has important roles in regulating the development of craniofacial
structures. For example, in postnatal stages of development, Nog
expression in cranial sutures prevents the premature fusion of
skull bones (craniosynostosis) (Warren et al., 2003). Nog null mice
display cleft palate, a defect ascribed to compromised integrity of
palatal epithelium due to the change in cell death and cell
proliferation rate (He et al., 2010). Further essential roles of Noggin
are revealed in the absence of Chordin (Anderson et al., 2002;
Stottmann et al., 2001), another BMP antagonist which when
lacking on its own has only very mild, non-lethal phenotypes
(Choi and Klingensmith, 2009). These Chrd;Nog double mutant
defects sometimes include dramatic truncations of the rostral
head, in association with holoprosencephaly (Anderson et al.,
2002; Bachiller et al., 2000). Such rostral defects are due at least
in part to defective Shh signaling from the prechordal plate and
Fgf8 signaling from the anterior neural ridge, organizing centers of
early forebrain patterning and growth (Anderson et al., 2002).
Independent of this early rostral requirement, these BMP
antagonists also function to promote mandibular development.
Whereas mice lacking the Chordin gene (Chrd) show a very low
penetrance of mild micrognathia (Choi and Klingensmith, 2009),
Chrd /;Nogþ / and Chrd/;Nog/ exhibit a spectrum of
mandibular hypoplasia, ranging from agnathia to micrognathia,
as a result of insufﬁcient NCC survival during mandibular bud
outgrowth (Stottmann et al., 2001). In contrast, in the absence of
Nog alone, mandibles are enlarged, reﬂecting increased size of the
transient Meckel's cartilage, around which mandibular bone is
formed (Stottmann et al., 2001; Wang et al., 2013). The mandible
forms via ossiﬁcation of cells from the NCC-derived perichondrium
at the periphery of Meckel's cartilage, which itself is composed of
both neural crest derivatives and other mesenchymal cells (Chai
et al., 2000a). Whereas the normal fate of chondrocytes in the
main portion of Meckel's cartilage is to degenerate, in Nogmutants
or in embryos expressing an activated BMP receptor transgene in
chondrocytes, these cells over-proliferate, then differentiate and
undergo ossiﬁcation (Wang et al., 2013).
These phenotypes all reveal important roles for Noggin in
regulating development of the craniofacial skeleton, but the
relevant spatiotemporal contexts of Nog expression are not clear
for any of these roles. During early stages of head development,
Nog is expressed in several potentially relevant domains
(Anderson et al., 2002; He et al., 2010; Lana-Elola et al., 2011;
Nifuji and Noda, 1999; Stottmann et al., 2001). Here we further
probe the expression of Nog in relation to development of the
viscerocranium. We then use a series of tissue-speciﬁc ablations of
the Nog gene to elucidate the cellular mechanisms of Noggin
function in mandibular and palatal development.
Results
Expression of Nog during formative craniofacial development
To gain insight into the possible roles of Noggin in development
of tissues derived from PA1, we assessed its spatiotemporal
expression using an assay for expression of a lacZ reporter
integrated into the published Nog null allele (Anderson et al.,
2002; Brunet et al., 1998; McMahon et al., 1998). Nog is expressed
transiently in migrating and postmigratory NCCs from the earliest
stages, with robust expression by at E8.5 (Fig. 1(A) and (B)). At E9.5
expression is observed in NCCs in PA1 (Fig. 1(C) and (E)). By E10.5,
its expression is greatly diminished in the PA1 mesenchyme and is
largely restricted to the arch ectoderm (Fig. 1(D) and (F)). Over this
timeframe Nog is also present in the notochord, the ﬂoor plate of
the neural tube, the dorsal foregut endoderm (Fig. 1(B) and (C)), as
well as the ventrolateral foregut endoderm in the laryngeal region.
Later, during palatal development at E11.5 and E13.5, Nog is
strongly expressed in the palatal epithelium (Fig. 1(G) and (H)).
Nog is also expressed in various cartilages; as previously observed
(Wang et al., 2013), this includes Meckel's cartilage from E12.5 and
later (Fig. 1G,H).
Loss of BMP antagonism speciﬁcally from axial domains results in
mandibular truncations but not cleft palate
The early onset and forebrain gene expression changes in Chrd;
Nog double mutants indicate that the axial midline expression of
these BMP antagonists is key for forebrain development (Anderson
et al., 2002). Given that in the absence of Chrd, loss of one or both
wildtype alleles of Nog can also result in mandibular hypoplasia,
independent of holoprosencephaly phenotypes (Anderson et al.,
2002; Stottmann et al., 2001), we sought to determine whether
the outgrowth defect also reﬂected loss of the axial domain of Nog,
or another early domain such as cranial NCCs. We tested the role of
axial Nog in craniofacial development by deleting Nog in the axial
midline from early stages, with or without the presence of a
wildtype Chrd allele. To remove Nog function exclusively from the
axial midline, we combined a conditional null allele of Nog (Nogfx)
(Stafford et al., 2011) with Shh-GFP-Cre (Harfe et al., 2004), a
recombination driver for the late node, notochord, and ﬂoor plate.
Because these are all sites of both Nog and Chrd expression, we
generated Shh-GFP-Cre;Noglacz/fx mutants with and without the
presence of Chrd. As expected from previous studies (Stottmann
et al., 2001; Anderson et al., 2002), we did not see holoprosence-
phaly or mandibular arch phenotypes in the Shh-GFP-Cre; Noglacz/fx
mutants in the presence of wildtype Chrd (data not shown). In
contrast, Shh-GFP-Cre; Noglacz/fx; Chrd/ embryos displayed par-
tially penetrant hypoplastic PA1 phenotypes, including diminished
mandibular and maxillary structures (3/5); some of these mutants
were holoprosencephalic as well (Fig. 2(A)–(D)). These data
collectively indicate that the rostral truncation phenotypes of
Chrd;Nog mutants, including both forebrain and mandibular arch
truncations, result from a deﬁcit of axial midline BMP antagonism
by Chordin and Noggin. Thus, Noggin function in axial midline
tissues promotes mandibular outgrowth, though none of these
tissues contribute to the mandible.
None of the embryos lacking Nog speciﬁcally in the axial
midline (Shh-GFP-Cre; Noglacz/fx;Chrd /) showed two relevant
defects of the Nog null: None exhibited a thickening of the
mandible (Fig. 2(G) and (H)), implying that some other deﬁcit of
Nog underlies the thickened mandible phenotype of the null
(Stottmann et al., 2001; Wang et al., 2013). Furthermore, the
embryos lacking axial Nog did not display cleft palate. This
indicates that the fully-penetrant cleft palate defect of Nog null
mutants (He et al., 2010) does not result from a lack of axial BMP
antagonism, but instead implies another tissue type must make
Noggin protein for proper development of craniofacial structures,
including palatogenesis.
Loss of Nog in neural crest cells results in an enlarged mandible
Since many craniofacial skeletal elements are derived from
NCCs, in which Nog is expressed (Stottmann et al., 2001), we
assessed potential roles of Nog in NCCs using Wnt1-Cre, an NCC
speciﬁc Cre driver (Danielian et al., 1998), in the development of
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craniofacial structures. In the head region, Wnt1-Cre is expressed
in the dorsal neural folds from early stages of cranial NCC
development, as well as in newly migrating NCCs (Jiang et al.,
2000; Stottmann and Klingensmith, 2011). Given that Chrd is
redundant with Nog in many developmental contexts (reviewed
by (Klingensmith et al., 2010), and that PCR data suggest Chrd is
expressed at low levels in NCCs (M. Choi and JK, unpublished
results), we tested the role of Nog in NCCs with and without
wildtype allele(s) of Chrd. We found that the craniofacial pheno-
types of Wnt1-Cre; Noglacz/fx animals were not noticeably different
from Wnt1-Cre;Noglacz/fx;Chrd/ (Supplementary Fig. 1). Regard-
less of Chrd's presence or absence, embryos lacking Nog from NCCs
displayed very similar if not identical craniofacial defects. As a
demonstration, the samples in Fig. 3 are from mutant animals of
the genotype Wnt1-Cre; Noglacz/fx;Chrd/ , whereas all other
ﬁgures depict results from mutants that were Wnt1-Cre; Noglacz/fx.
A striking phenotype in embryos lacking Nog in NCCs is an
enlarged mandible (Figs. 3 and 4(A) and (B)), very similar to that of
Nog null mice (Stottmann et al., 2001; Wang et al., 2013). Other
craniofacial skeletal derivatives of NCCs, including laryngeal struc-
tures such as the hyoid and thyroid cartilages, were also hyper-
morphic in the mutant embryos (Supplementary Fig. 2). Our
results indicate that the thickened mandible phenotype of Nog
mutants is due speciﬁcally to a lack of Noggin in NCCs, implying
that attenuation of BMP signaling in the immediate environment
of NCCs is necessary for proper mandibular morphogenesis.
Fig. 1. Nog is expressed in multiple domains during craniofacial development. (A) and (B) Nog is ﬁrst expressed in migrating NCCs around E8.0. (C) Nog is expressed in the
NCCs of PA1. (D) By E10.5 Nog expression is restricted to the oral epithelium of PA1. (E) and (F) Sections through PA1 showing transient expression of Nog. At E9.0, Nog
expression is found in mesenchyme of PA1 (E), but Nog expression subsequently shifts to the epithelium layer of PA1 (F). (G) and (H) Nog is expressed in the cartilages of the
head. pa1; pharyngeal arch 1, fp; ﬂoor plate of the neural tube, mc; Meckel's cartilage, nccs; neural crest cells, ns; nasal septum, oe; oral epithelium.
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Neural crest migration into PA1 occurs normally in embryos lacking
Nog in NCCs
We investigated the mechanisms underlying the enlarged man-
dibular skeletal element. A potentially relevant ﬁnding is that BMP
signaling promotes delamination and collective migration of NCCs
(Burstyn-Cohen and Kalcheim, 2002; Hall and Erickson, 2003). In so
far as Chrd/;Nogþ / embryos have increased neural crest produc-
tion from the neural tube (Anderson et al., 2006), we hypothesized
that ablating Nog from NCCs might increase production and migration
of NCCs into the pharyngeal arches. However, we observed that the
size of the PA1 in mutant embryos was not noticeably larger than that
in wild type littermates at E10.5, when NCC migration is completed
(Supplementary Fig. 3). We also assessed the expression of pharyngeal
arch markers, including Dlx2, Dlx5, Msx1, and Barx1 (Supplementary
Fig. 3). We detected no altered expression relative to wild type
embryos, suggesting normal early patterning of the arch mesenchyme
and ectoderm. These results suggest that altered NCC production and
emigration into PA1 are not the primary cause of the enlarged
mandibular skeleton observed in Wnt1-Cre;Noglacz/fx mutants.
Fig. 2. BMP antagonism in axial domain is critical for development of PA1 derivatives. (A)–(D) Lateral view of wild-type (A) and (C) and Shh-GFPCre;Noglacz/fx;Chrd/ (B) and
(D) mutant whole-mount and skeletal-preparation heads at P0 stage showing that a lack of Chrd and Nog in the Shh-GFPCre domain results in hypomorphic PA1 derivatives
compared with wild-type littermates. Scale bars¼2 mm. (E) and (F) Example of holoprosencephaly in mutant embryo at E16.5 (F), and with a normal littermate (E). (G), and
(H) Mutant embryos without obvious phenotypes showing relatively normal development of the palate (indicated with an arrow) and Meckel's cartilage (indicated with
arrowheads (H)). Scale bars¼1 mm.
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Cell proliferation in Meckel's cartilage and perichondrium is increased
in the absence of Nog in neural crest derivatives
To probe the cause of the enlarged mandible in mutants lacking
Nog in NCCs, we performed cell proliferation assays in Meckel's
cartilage using a BrdU incorporation and detection assay to mark
proliferating cells. Meckel's cartilage ﬁrst forms as a cartilage
condensation around E11.5. At this stage, there is little difference
in the size of the condensation between wild type and mutant
embryos (Fig. 4(C) and (D)). However, by E12.5, Meckel's cartilage
begins to grow faster and larger in mutants relative to wild type
littermates. Cell proliferation is increased at E12.5 both in the
mesenchyme and in the perichondrium of mutant Meckel's
cartilage, and the diameter of Meckel's cartilage grows continu-
ously larger in the mutant than in wild type until E15.5 (Fig. 4(E),
(F), (J) and (K)).
Previous studies suggest that Hh signaling may regulate cell
proliferation during mandibular development. For example, lack of
Hh signaling in NCCs results in a hypoplastic mandible (Jeong
et al., 2004; Melnick et al., 2005), whereas activating Hh signaling
in NCCs increases the size of facial primordial (Jeong et al., 2004).
Accordingly, one hypothesis for the increased mandibular size and
cell proliferation in embryos lacking Nog in NCCs is upregulation of
Hh signaling when BMP receptor activation is increased in NCCs
due to a loss of Nog from these cells.
To investigate if activating BMP signaling in NCCs induces
ectopic Hh signaling in the developing mandible, we assessed
the state of Hh signaling upon forced elevation of BMP signaling in
NCCs. To do this, we drove expression of an activated BMP receptor
1A (caBMPr1a) transgene (Rodriguez et al., 2010) speciﬁcally in
NCCs, and included a Ptch1-lacz transgene, an established, obligate
reporter of Hh signaling (Goodrich et al., 1997). At E13.5, Ptch1-
lacz staining was apparent in the Meckel's cartilage of theseWnt1-
Cre; caBMPr1a; Ptch1-lacz mutants, while no blue cells were found
in the wild-type Meckel's cartilage (Fig. 4(G) and (H)). We also
performed quantitative real time PCR (qPCR) to assess the level of
Hh signaling and to determine if the increased Hh signaling
activity might be reﬂected by increased expression of any Hh
ligand. Our qPCR results showed increased expression of Hh
transcriptional target genes at E12.5 (Fig. 4(L)). Moreover, we
observed that Indian hedgehog (Ihh) expression is signiﬁcantly
increased in the mutant mandible. Together, these data suggest
that in mandibular NCCs, increased BMP receptor activation leads
to increased Ihh transcription, which then leads to increased Hh
signaling, a putative NCC mitogen. This in turn implies that the
enlarged mandibular phenotype of embryos lacking Nog in NCCs
may result from increased cell proliferation caused by elevated Hh
signaling.
Absence of Noggin in NCCs results in secondary cleft palate
Beyond an enlarged mandible, loss of Nog expression in NCCs
also results in other craniofacial skeletal defects. While many
defective skeletal elements are enlarged in mutants, such as the
nasal cartilage, hypoplasia occurs in a few membranous bones,
such as the palatal bone (Fig. 8(J) and (K)) and those of the cranial
vault (data not shown). Although primary palatal development
appeared unaffected in embryos lacking Nog speciﬁcally in neural
crest derivatives, Wnt1-Cre;Noglacz/fx embryos show overt second-
ary cleft palate (Fig. 5). Although the cause of cleft palate in Nog
mutants was previously attributed to a lack of Nog expression in
the oral epithelium (He et al., 2010), our results indicate that a key
contributor to the cleft palate phenotype in Nog nulls is a lack of
Nog in NCCs.
To investigate the etiology of the palatal defects in Wnt1-Cre;
Noglacz/fx mutant mice, we performed detailed morphological and
histological analyses of palatal shelves at different stages of
development. We ﬁrst assessed the growth of the palatal shelves.
At E13.5 palatal shelves of control and mutant embryos showed no
clear differences in shape or size (Fig. 6(A) and (F)). We used a
BrdU incorporation assay to assess cell proliferation in the palatal
shelf mesenchyme at this stage. We saw no signiﬁcant difference
between wild type and mutant embryos (Fig. 6(M) and (N)). Thus
both the gross size and shape of the palatal shelves, as well as cell
Fig. 3. Absence of Nog in NCCs causes craniofacial defects. (A) and (C) Anterior and posterior coronal sections through E15.5 wild-type embryonic head showing fusion of the
palatal shelves and normal development of cartilages in the head. (B) and (D) Anterior and posterior coronal sections ofWnt1-Cre;Noglacz/fx;Chrd/mutant embryos showing
cleft palate and enlarged cartilages at E15.5. ps; palatal shelves, t; tongue, mc; Meckel's cartilage. Scale bars¼400 μm.
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Fig. 4. An enlarged Meckel's cartilage with increased cell proliferation results from upregulation of BMP signaling in neural crest derivatives. (A) and (B) Mandibular skeletal
preparations. Wild type mandible (A) shows normal development of Meckel's cartilage (blue) and mandibular bone (purple). Double headed arrow shows antero–posterior
(a-p) direction of mandibular outgrowth. Enlarged Meckel's cartilage in Wnt1-Cre;Noglacz/fx mutant (B) shows no obvious outgrowth defects. Scale bar¼1 mm. (C) and
(D) Meckel's cartilage surrounded by a red dotted line. The size of wild type (C) Meckel's cartilage is similar to mutant (D) at E11.5. Scale bars¼100 μm. (E) and (F) Cell
proliferation in Meckel's cartilage as indicated by BrdU incorporation. Compared with cell proliferation in wild-type Meckel's cartilage (E), cell proliferation was increased in
the mutant Meckel's cartilage at E12.5 (F). Scale bars¼100 μm. (G) and (H) Meckel's cartilage surrounded by a red dotted line. Expression of a constitutively active BMP
receptor 1a (caBMPr1a) in combination with Wnt1-Cre caused ectopic expression of Hh signaling in mutant Meckel's cartilage, as revealed by blue staining of Ptch-lacz
activity at E13.5 (H). Wild-type (G) Meckel's cartilage showed no beta-galactosidase activity. Scale bar¼100 μm. (I) Mandibular outgrowth in the antero–posterior direction
as shown in (A) is not different between wild-type and mutant embryos. (J) The diameter of Meckel's cartilage showed similar size between wild-type and mutant at E11.5.
However, after E12.5 mutant Meckel's cartilage started rapidly growing and the growth persisted at E15.5, while growth rate in wild-type Meckel's cartilage was diminished.
(K) Increased cell proliferation in both perichondrium (peri) and mesenchyme (mes) in Meckel's cartilage of Wnt1-Cre;Noglacz/fx mutant was statistically signiﬁcant at E12.5.
(L) qPCR indicates increased expression of Hh signaling targets (Gli1, Ptch1) and the Ihh ligand gene in the mutant Meckel's cartilage at E12.5. Po0.05.
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proliferation within the largely NCC-derived mesenchyme, show
no difference.
We next tested whether patterning markers are correctly
expressed in the mutant palatal shelves. During palatal develop-
ment, speciﬁc genes are expressed along the anterior–posterior
axis of the secondary palatal shelves. These gene expression
patterns are informative markers to assess patterning defects in
the mutant palatal shelves. Shox2 is normally expressed in the
anterior palatal shelves (Yu et al., 2005). Shox2 null mice exhibit a
rare form of cleft palate in which primary and secondary palatal
shelves do not fuse properly (Yu et al., 2005). Shox2 expression is
greatly reduced in the anterior palatal shelves of Nog null embryos
at E13.5 (He et al., 2010). By contrast, Shox2 expression was not
altered in the palatal shelves of Wnt1-Cre;Noglacz/fx embryos (Fig. 7
(A) and (E)). This indicates that it is not the NCC domain of Nog
that regulates Shox2 expression, though Nog appears to do so in
some other palatal context.
Besides being a patterning marker for the developing palate,
Tbx22 is also a context-dependent downstream target gene of BMP
signaling (Higashihori et al., 2010). Explant culture experiments
using facial primordia and palatal shelves suggest that Tbx22
expression is regulated by BMP signaling (Fuchs et al., 2010). Its
expression in the palatal shelves occurs posteriorly. Loss of Tbx22
results in submucous cleft palate in mice and human (Braybrook
et al., 2001). Tbx22 null mice show reduced palatal bone due to
delay in the osteoblast maturation (Pauws et al., 2009). However,
in situ hybridization results showed that Tbx22 expression is
not altered in the Wnt1-Cre;Noglacz/fx mutant palatal shelves at
E13.5. qPCR analysis also indicates that expression level of Tbx22
is unchanged in the mutant palatal shelves relative to wild type
tissue (Supplementary Fig. 4), although the eventual size of the
palatal bone is greatly reduced (Figs. 7(B) and (F), and 8(J) and (K)).
These results, as well as the lack of evidence for a change in cell
proliferation in the mutant palatal shelves suggest that altered
Tbx22 expression in theWnt1-Cre;Noglacz/fx palatal shelves is not the
main cause of the smaller palatal bone and cleft palate in this
mutant. Two other palatal shelf markers, Barx1 and Efnb2, are also
similarly expressed between wild-type and mutant embryos (Fig. 7
(C), (D), (G), and (H)). Collectively, our results with gene expres-
sion markers of palatal pattern formation suggest that patterning
Fig. 5. Nog in NCCs is required for proper palatogenesis. (A) and (B) Ventral views of palatal structure. A wild-type E15.5 mouse (A) showing normal palatal development in
which the palatal shelves have fused by this stage, compared with the secondary cleft palate in aWnt1-Cre;Noglacz/fx embryo (B). (C) and (D) Ventral views of palatal structure
in newborn pups (P0). A wild-type P0 mouse showing normal palatal development (C). Overt cleft palate in Wnt1-Cre;Noglacz/fx is obvious at P0 (D). Scale bars¼1 mm.
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failures are not a major cause of the cleft palate phenotype that
occurs when Noggin is absent from neural crest derivatives.
Nog in NCCs is not required for palatal fusion
One of the common causes of cleft palate is a defect in palatal
fusion. For the bilateral palatal shelves to properly fuse, the two
sides need to be closely juxtaposed, with their binding aided by
secretion of extracellular matrix (d'Amaro et al., 2012; Gato et al.,
2002; Morris-Wiman and Brinkley, 1992). Upon contact of the
opposing palatal shelves, dynamic tissue remodeling, including
apoptosis and changes in gene expression, occur at the medial
edge epithelium (MEE) (Huang et al., 2011; Nawshad et al., 2007;
Xu et al., 2006). To test whether the neural crest domain of
Nog is important for palatal fusion per se, we performed palatal
shelf explant cultures. Palatal shelves were harvested from E13.5
embryos, and then placed in contact with each other in culture
medium such that their medial surfaces were juxtaposed. After
72 h, both wild-type and mutant palatal shelves fused normally
(Fig. 7(I) and (J)). These data indicate that Nog expression in neural
crest derivatives is not necessary for palatal fusion, in turn
suggesting that failure of palatal shelf fusion is not the cause of
the secondary cleft palate phenotype that occurs when Noggin is
absent from NCCs.
Failed palatal shelf elevation likely results from dysmorphic skull
base structure
As noted above, the size of the palatal shelves in Wnt1-Cre;
Noglacz/fx mutant embryos prior to palatal shelf elevation showed
Fig. 6. Palatal shelf development in Wnt1-Cre;Noglacz/fx appears normal before elevation. (A)–(F) Anterior to posterior level matched coronal sections of E13.5 control
(A)–(C) and mutant (D)–(F) littermates. (G)–(L) Anterior to posterior level matched coronal sections of E14.5 control (G)–(I) and mutant (J)–(L) littermates. Sections shown in
the left column (A) and (D) are anterior secondary palate. Sections shown in the left column (G) and (J) are from the elevated secondary palate region. Mutant palatal shelves
(J) often show incomplete elevation of palatal shelves. Sections shown in the middle column (B), (E), (H) and (K) are from the middle of the secondary palate region. Sections
shown in the right column (C), (F), (I), and (L)) are from the posterior soft palate region. (M) and (N) numbers of BrdU-positive cells per unit area in the palatal shelves of
E12.5 (M) and E13.5 (N) were counted and compared betweenwild-type andWnt1-Cre;Noglacz/fx mutant littermates. They showed no statistically signiﬁcant difference in cell
proliferation. ns, nasal septum; ps, palatal shelf. Scale bars¼400 μm.
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no overt differences relative to wild-type samples at E13.5.
However, at E14.5 anterior palatal shelves were elevated horizon-
tally above the tongue, yet were not close to each other; by
contrast, control palatal shelves were fusing at this stage (Fig. 6
(G) and (L)). We observed that the angle of the mutant palatal
shelves became wider progressively from anterior to posterior
(Fig. 8(E) and (F)).
Upon analysis of sectioned samples, we observed ectopic
skeletal element invasion into the posterior palatal shelves of
mutant embryos at E13.5, at a stage in which palatal shelf
elevation has not started (Fig. 8(A) and (B)). By E14.5, the ectopic
skeletal tissue occupied much of the posterior palatal structure
(Fig. 8(C) and (D)). Analysis of stained skeletal preparations
revealed that the ectopic skeletal element in the posterior palatal
shelves was an enlarged, dysmorphic pterygoid bone (Fig. 8
(H) and (K)). The pterygoid is a neural crest derivative
(McBratney-Owen et al., 2008), and thus is the product of cells
devoid of Noggin.
Beyond the pterygoid's direct disruption of palatal structure,
we also observed that the antero–posterior (AP) and medial–
lateral (ML) lengths of skull base structure were abnormal in
mutants. The AP length of mutant skull base was signiﬁcantly less
while the ML width of mutant skull base was wider than those
of wild-type embryos (Fig. 8(J)–(L)). We also found that the
presphenoid and the basisphenoid bones in mutant embryos
fused inappropriately (Fig. 8(J) and (K)). It seems probable that
the shorter skull base caused by abnormally fused presphenoid
and basisphenoid bones displaces an enlarged pterygoid bone
anteriorly, which in turn allows the enlarged pterygoid bone
to invade into the posterior palatal shelves, preventing proper
elevation of the palatal shelves in the mutant lacking Nog in NCCs.
Similar phenotypes were observed in Nog null embryos
(Supplementary Fig. 5).
Discussion
In this study, we used tissue speciﬁc gene knockout mouse
models to probe the roles of two distinct domains of Nog in
regulating craniofacial development. We found that the axial
midline domain of BMP antagonism is critical for outgrowth of
the mandibular bud of PA1, which swells with the immigration of
NCC cells. Our data suggest an indirect effect of axial Noggin in
promoting the survival of these NCCs. Later, in NCCs and their
derivatives, Nog activity regulates development of mandibular and
maxillary craniofacial skeletal elements that are derived from
NCCs. By upregulating BMP signaling in NCCs, loss of Noggin
caused Meckel's cartilage to become strikingly enlarged as a result
of greatly increased cell proliferation; this was accompanied by
increased Hh signaling, a possible mitogenic cue for some NCC
derivatives. We also found that mutants lacking Nog in NCC
derivatives show secondary cleft palate, likely due to defects in
bones of the skull base, particularly an enlarged pterygoid.
Together, these results reveal distinct roles of Noggin in axial
domains for early PA1 development and in the NCC lineage for
regulating later development of craniofacial skeletal elements.
Fig. 7. Lack of Nog in NCCs does not prevent normal patterning or fusion steps of palatal development. (A)–(E) Anterior and posterior local patterning characteristics in the
secondary palatal shelves are not altered in the Wnt1-Cre;Noglacz/fx mutant mice. (A) and (E) Shox2 mRNA expression was restricted to the anterior palatal shelves in E13.5
wild-type (A) and mutant (E) littermates. (B)–(D, (F)–(H) Expression of Tbx22 (B) and (F), Barx1 (C) and (G), and Efnb2 (D) and (H) mRNAwas restricted to the posterior region
of the E13.5 palatal shelves in both wild-type (B)–(D) and mutant (F)–(H) embryos. (I) and (J) Histological sections of cultured wildtype (I) and Wnt1-Cre;Noglacz/fx mutant
(J) palatal shelves juxtaposed in culture show that both genotypes can fuse normally. Arrowheads indicate the point where palatal shelf fusion has taken place. Scale
bars¼100 μm.
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BMP antagonism by Noggin and Chordin from the axial midline
promotes mandibular outgrowth
Our previous studies with Chrd /;Nog / and Chrd /;Nogþ /
 embryos revealed a requirement for the Chordin and Noggin
BMP antagonists in proper generation of the NCCs that populate
PA1 (Anderson et al., 2006; Stottmann et al., 2001). Lowering the
genetic dosage of Nog in the absence of Chrd caused an increased
emigration of NCCs from the dorsal neural folds, but instead of
expanded mandibular buds, they were deﬁcient; this was because
a high level of NCC apoptosis in the pharyngeal region (Anderson
et al., 2006). One possibility was that lack of expression of these
BMP antagonists in NCCs causes their death and the resulting
mandibular hypoplasia. This is not the case, because we saw no
outgrowth defect when we ablated Nog speciﬁcally in NCCs,
regardless of whether Chrd was present or not. Instead, we found
that in the absence of Chrd, ablating Nog from the axial midline
(notochord and ﬂoor plate) results in mandibular hypoplasia very
similar to that observed in Chrd;Nogmutants. If Chrdwere present,
loss of Nog from the axial midline had no such effect. The axial
midline domain of Nog is therefore the relevant source of expres-
sion, in which it is redundant with Chrd.
Our results imply that decreased BMP antagonism at the axial
midline leads to a failure to attenuate BMP signaling in the
Fig. 8. Pterygoid bone disrupts the posterior palatal shelves in the Wnt1-Cre;Noglacz/fx mutant palate. (A)–(F) Coronal sections of heads from E13.5 and E14.5, comparing
palatal structure in wild type and Wnt1-Cre;Noglacz/fx mutants. Before palatal shelf elevation at E13.5, the pterygoid bone is not obvious in this plane of section in the wild-
type embryo (A), but it is already much larger in the mutant and invades into the posterior part of palatal shelves (B). (C) and (D) Coronal sections through posterior palate at
E14.5. The pterygoid bone appears in wild-type at E14.5 (C), while it intrudes much further into mutant palatal shelves at this stage (D). (E) and (F) Coronal sections of palatal
bone region at E14.5. Completely elevated and fused wild-type palatal shelves (E), whereas palatal shelves were elevated but the angle of elevation was wider in the
Wnt1-Cre;Noglacz/fx mutant littermate (F). (G) The angle of palatal elevation was recorded and compared between wild-type and mutant littermates. (H) and (I) Skeletal
preparation showing ventral view of the posterior skull base and the palate. Compared with the width of wild-type skull (H), the width of mutant skull is wider (I). (J) and
(K) Isolated skull base and the palatal bone region from the skeletal preparations at E17.5. The bilateral palatal bones are in contact in wild-type embryo (J). In the mutant (K),
the palatal bones are smaller and far apart, the pterygoid bone is enlarged and dysmorphic. (L) The length and width of the skull base were recorded and compared between
wild-type and mutant skeletal preparations at E17.5. pb, palatal bone; pt, pterygoid bone; prs, presphenoid; bs, basisphenoid; a, anterior; p, posterior; ml, medial–lateral.
nP-valueo0.05, nnP-valueo0.01. Scale bars¼100 μm for (A), (B), (C), and (D), 500 μm for (E) and (F).
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pharyngeal environment as NCCs migrate through to populate the
mandibular arch. One possibility is that increased BMP signaling in
NCCs causes their apoptosis. If this were true, then expression of
an activated BMP receptor in NCCs should cause their apoptosis.
When we did this experiment, by expressing an activated BMP
receptor (Rodriguez et al., 2010) in migratory NCCs, we saw the
opposite phenotype—an enlarged mandible. Therefore, it is more
likely that increased BMP activity caused by loss of axial BMP
antagonism is leading to lower levels of an NCC survival cue. Fgf8
has been shown to promote NCC survival during mandibular
outgrowth. We previously found that pharyngeal Fgf8 expression
is reduced in Chrd;Nog mutants, and that beads soaked in BMP
caused decreased expression of Fgf8 in mandibular arch explants,
whereas beads soaked in carrier had no effect (Stottmann et al.,
2001). Together with these earlier results, our data further support
a mechanism in which reduced axial BMP antagonism leads to
increased pharyngeal BMP activity, which in turn reduces expres-
sion of Fgf8 in the pharyngeal ectoderm and endoderm. This in
turn results in less NCC survival as these cells colonize and
populate the mandibular bud (Fig. 9).
Nog expression in NCCs regulates Meckel's cartilage and mandibular
development
As noted above, loss of Nog expression from the NCCs, via
tissue-speciﬁc gene ablation with Wnt1-Cre, resulted in an
enlarged mandible. The enlarged mandibular phenotype is very
similar to that seen in Nog nulls (Supplementary Fig. 5) (Stottmann
et al., 2001; Wang et al., 2013). This phenotype was not noticeably
different from Wnt1-Cre;Noglacz/fx;Chrd/ , showing that loss of
Chrd makes no difference when Nog is deleted speciﬁcally in the
NCCs. In contrast, when the BMP antagonists Chordin and Noggin
are both absent from the outset, mandibular bud outgrowth is
deﬁcient, and mandibular structures are greatly truncated. Thus in
mandibular development per se, as opposed to mandibular bud
outgrowth, there appears to be no redundancy of Nog with Chrd.
Our results are consistent with a recent study which reported that
BMP4 overexpression in NCCs at E12.5 resulted in a similar
enlargement of Meckel's cartilage (Bonilla-Claudio et al., 2012).
Earlier in development, embryos lacking Nog in NCCs (Wnt1-Cre;
Noglacz/fx mice) showed normal size pharyngeal arches, and several
Fig. 9. Summary and model of the roles of Nog in development of craniofacial structures. (A) Nog is expressed in two relevant domains for craniofacial development—NCCs
and axial midline. When Nog is ablated in NCCs, an enlarged mandible and cleft palate result without mandibular outgrowth defects. When the axial midline domain of Nog
is absent, as well as Chordin, encoding a second midline BMP antagonist, mandibular outgrowth defects and holoprosencephaly occur. Nog null mutant embryos exhibit
phenotypes of both of these tissue-speciﬁc mutants combined: enlarged mandible, cleft palate, mandibular outgrowth defects, and holoprosencephaly. (B) Earlier expression
of Nog in axial domains promotes NCC survival by promoting secondary cues such as Fgf8 and Hh signaling. However, at later stages, Nog regulates skeletogenesis by
balancing the level of BMP signaling in and around NCC derivatives. In chondrocytes, Nog regulates the size of cartilage by suppressing cell proliferation. When BMP
attenuation is insufﬁcient, chondrocyte proliferation is promoted, possibly through ectopic Ihh expression and Hh pathway signaling.
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arch markers that are also BMP downstream target genes showed
normal expression patterns at E10.5 (Supplementary Fig. 3). These
results further suggest that Nog activity in NCCs is not necessary
for early stages of mandibular development, but rather is neces-
sary for proper skeletogenesis within the developing mandibular
prominence.
We found that the enlarged mandible phenotype occurred not
only when Nog was ablated from NCCs via Wnt1-Cre, but also
when the same recombination driver was used to express an
activated BMP receptor in NCCs. This result suggests that the NCCs
themselves, and their derivatives, need attenuation of BMP signal
transduction to undergo proper development in the mandibular
bud. These derivatives are likely to be chondrocytes, as expression
of an activated BMP receptor construct in these cells results in a
similarly enlarged mandible as a result of expanded Meckel's
cartilage (Wang et al., 2013).
Our studies with Wnt1-Cre;Noglacz/fx mutants indicated greatly
increased cell proliferation in the perichondrial area of Meckel's
cartilage relative to normal controls. A similar increase in cell
proliferation was noted in embryos expressing an activated BMP
receptor in chondrocytes (Wang et al., 2013). Consistent with
studies suggesting the ability of BMP signaling upregulation in
NCCs to cause increased cell proliferation in Meckel's cartilage (Hu
et al., 2008; Wang et al., 2013), the increased size of the mandible
may be a direct effect of an increased level of chondrocyte
proliferation triggered by less attenuation of BMP signaling by
Noggin. An alternative explanation is that the increased prolifera-
tion results form some other cue. We found that a known positive
cytokine regulator of chondrocytic cell proliferation, Indian hedge-
hog (Ihh) (Minina et al., 2001), was expressed at increased levels
when BMP signaling was upregulated in the NCC lineage. Accord-
ingly, a second possibility is that in the context of the developing
Meckel's cartilage, BMP signaling in NCCs positively regulates Ihh
activity, which in turn promotes chondrocyte proliferation. At least
in endochondral ossiﬁcation, BMP signaling is reported to posi-
tively regulate Ihh expression which, in turn, promotes cell
proliferation (Minina et al., 2002). This may be true in Meckel's
cartilage as well. A caveat to this model is that in the absence of
Ihh, in mutants lacking the gene, the size of the mandible is not
greatly diminished (St-Jacques et al., 1999). We would thus posit
that Ihh can promote chondrocyte proliferation in Meckel's carti-
lage, but is not essential for it. In any case, we suggest that a key
function of Noggin in chondrocytes derived from NCC cells is to
limit proliferation by attenuating BMP activity (Fig. 9).
Noggin activity and the regulation of palatal development
In addition to an enlarged mandible, Wnt1-cre;Noglacz/fx
embryos exhibited almost fully penetrant secondary cleft palate.
A previous study characterized the cleft palate of the Nog null (He
et al., 2010), which also includes primary cleft palate. Nog is
expressed in the oral epithelium, which showed increased cell
death in Nog null mutants. He et al. (2010) expressed activated
BMP receptor in the epithelium, and found that the resulting
embryos had cleft palate. These ﬁndings suggested that the cleft
palate of Nogmice results from increased BMP signaling in the oral
epithelium. By contrast, we have found that ablation of Nog
exclusively in the NCC lineage, which contributes to the mesench-
yme but not the epithelium of the forming palate, also causes
severe secondary cleft palate. Together, these studies suggest that
Nog plays multiple tissue-speciﬁc roles in palatal development
(Fig. 9(A)).
Palatal shelves from embryos lacking Noggin activity in NCC
derivatives could fuse seemingly as well as in wild type in tissue
culture experiments, but in the context of the rest of the mutant
viscerocranium in vivo, they likely never get close enough. The
mutant palatal bones were hypomorphic, which in principle could
directly cause submucous cleft palate. However, the primary cause
of overt cleft palate in Wnt1-cre;Noglacz/fx embryos seems more
likely to be an indirect effect of defective viscerocranial skull
formation which in turn disrupts posterior palatal morphogenesis.
Palatal shelf elevation was likely inhibited by the presence of an
enlarged pterygoid bone that is located posterior to the palatal
shelves. The pterygoid precursor is derived from NCCs and devel-
ops through endochondral ossiﬁcation (McBratney-Owen et al.,
2008). These data suggest that a dysmorphic skull base element
can greatly inﬂuence palatogenesis.
We further observed that in mouse fetuses lacking Nog in NCC
derivatives, the skull base was shorter and wider than in wild type
animals. Studies concerning human patients show great correla-
tions between morphological anomalies in the skull base and the
incidence of cleft palate. For example, in 3-month-old children
with complete cleft, there was an increased width of the cranial
base in newborns, compared with patients with incomplete cleft
(Molsted et al., 1993; Molsted et al., 1995). Although a correlation
between complete clefts and skull base anomalies was found, it is
difﬁcult to establish etiology from these results. Our mouse model
suggests a mechanism of cleft palate in such cases: An abnormally
formed bone outside those directly involved in palatal develop-
ment can inﬂuence overall structural development of the skull
base and indirectly cause cleft palate. It is likely that morpholo-
gical anomalies in the skull base that affect palatal development
are overlooked as part of the etiology of cleft palate.
Materials and methods
Mouse strains
The Nogfx/fx conditional (Stafford et al., 2011), NoglacZ/þ (Brunet
et al., 1998), and constitutively active Bmpr1a conditional mice
(caBmpr1a), conditional mice were maintained on a mixed back-
ground. Wnt1-Cre mice (Brewer et al., 2004; Chai et al., 2000b;
Jeong et al., 2004; Jiang et al., 2000) were crossed with Noglacz/þ to
generate Wnt1-Cre;Noglacz/þ male mice, which were subsequently
crossed with Nogfx/fx to conditionally knockout Nog from neural
crest cells. As a complementary experiment, caBmpr1a, which have
been described previously (Rodriguez et al., 2010), were crossed
with Wnt1-Cre to activate BMP signaling in NCCs.
Histology, immunohistochemistry, and X-gal staining
For histology, embryos were harvested from pregnant mice,
ﬁxed in 4% paraformaldehyde (PFA) at 4 1C for 2 h to overnight
depending on gestation stage, dehydrated through graded alco-
hols, embedded in parafﬁn wax and sectioned at 10-um thickness.
The sections were stained with hematoxylin and eosin for histo-
logical observations.
Whole embryos were stained with X-gal overnight at room
temperature (RT). For X-gal staining in sectioned material,
embryos were ﬁxed 2 h to overnight embedded in OCT compound
(Sakura Finetek) after a sucrose gradient (15% and 30% sucrose in
PBST). Cryosections were cut at 10 um thickness and stained with
X-gal.
Skeletal preparations and in situ hybridization
For skeletal preparation, embryos were skinned, ﬁxed in 95%
ethanol overnight, stained with 0.05% alcian blue, washed in 95%
ethanol for 6hours to overnight and cleared in 2% KOH. Further, to
stain bone, embryos were placed in 0.005% alizarin red in 0.9 N
acetic acid and 60% ethanol overnight at room temperature and
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cleared with 1% KOH for overnight followed by 20% glycerol in 1%
KOH until cleared.
For whole mount in situ hybridization, embryos were dissected
from pregnant mice, ﬁxed overnight in 4% PFA at 4 1C. The ﬁxed
embryos were dehydrated through 25%, 50%, 75%, and 100%
ethanol, and stored in 100% ethanol at 20 1C. Whole mount
in situ hybridization was carried out using previously described
protocol (Belo et al., 1997) with hybridization temperature of
65 1C.
Palatal shelf organ culture
Palatal shelves were cultured according to previously described
methods (Brunet et al., 1995; Taya et al., 1999). Palatal shelves
were removed at E13.5 from wild type and Wnt1-Cre;Noglacz/fx
embryos. Paired palatal shelves were placed on 0.3 μm Millipore
ﬁlters with medial edge epithelia (MEE) in contact. Initially, paired
palatal shelves were cultured in Minimal Essential Medium with
Earle's salts and L-glutamine (Gibco) supplemented with 1% anti-
anti (Gibco) at 37 1C in a 5% CO2 air environment. After 24 h
culture the paired palatal shelves were submerged in DMEM with
Earle's salts and L-glutamine (Gibco) supplemented with 5% FBS
for another 48 h. After total 72 h of culture, paired palatal shelves
were ﬁxed in 4% PFA and processed for parafﬁn blocks and
sectioned at a 10-μm thickness as described above.
Quantitative real-time reverse transcription-polymerase chain
reaction (q-PCR)
RNA was puriﬁed from E12.5 and E13.5 palatal tissue or
mandibles from wild type and mutant samples using Trizol
reagents (Invitrogen). Following RNA extraction, cDNAwas synthe-
sized using iScriptTM cDNA Synthesis Kit (BIO RAD). Quantitative
PCR ampliﬁcations were performed in a StepOnePlus real-time
PCR machine (Applied Biosystems) using the SensiMixTM SYBR &
Fluorescein Kit (Bioline). For each gene, the PCR reaction was
carried out in triplicates and the relative levels of mRNAs were
normalized to that of HPRT using the normalized expression
method. Student's t-test was used to analyze the signiﬁcance of
difference and a P-value less than 0.05 was considered statistically
signiﬁcant.
Detection of cell proliferation
For detection of cell proliferation in the palatal shelves, preg-
nant female mice were injected once intraperitoneally at gesta-
tional day 12.5 and 13.5 with BrdU Labeling Reagent (50 μg/g body
weight; Roche). 30 min after injection, embryos were dissected,
ﬁxed with 4% PFA overnight at 4 1C and embedded in parafﬁn for
10 μm-thickness coronal sectioning. To detect BrdU, rat anti-BrdU
(1:500; Accurate Chemical & Scientiﬁc) and Alexa Fluor-
conjugated secondary antibody (1:500; Invitrogen) were used.
Following BrdU immunostaining, cell counts were recorded for
each of the bilateral palatal shelves of matching areas of anterior
secondary palate and of posterior secondary palate regions in the
wild type and mutant samples. The cell proliferation rate was
calculated as the number of the cell nuclei with BrdU labeling.
Alternatively, mouse anti-phosphorylated histone H3 (1:500; cell
signaling) and Alexa Fluor-conjugated secondary antibody (1:500;
Invitrogen) were also used to detect dividing cells. Data were
collected from at least three pairs of mutant and wild type
littermates at each developmental stage. Students' t-test was used
to analyze the signiﬁcance of difference and a P-value less than
0.05 was considered statistically signiﬁcant.
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